Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fibrosis and alcohol-related liver disease
Carolin Lackner, Dina Tiniakos
Journal of Hepatology (2019) Vol. 70, Iss. 2, pp. 294-304
Open Access | Times Cited: 231

Showing 1-25 of 231 citing articles:

MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease
Mohammed Eslam, Arun J. Sanyal, Jacob George, et al.
Gastroenterology (2020) Vol. 158, Iss. 7, pp. 1999-2014.e1
Open Access | Times Cited: 2561
EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis – 2021 update
Annalisa Berzigotti, Emmanuel Tsochatzis, Jérôme Boursier, et al.
Journal of Hepatology (2021) Vol. 75, Iss. 3, pp. 659-689
Open Access | Times Cited: 1128
Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification
Saranya Chidambaranathan Reghupaty, Paul B. Fisher, Devanand Sarkar
Advances in cancer research (2020), pp. 1-61
Open Access | Times Cited: 602
Cellular and Molecular Mechanisms Underlying Liver Fibrosis Regression
Alessandra Caligiuri, Alessandra Gentilini, Mirella Pastore, et al.
Cells (2021) Vol. 10, Iss. 10, pp. 2759-2759
Open Access | Times Cited: 164
The BRD7-P53-SLC25A28 axis regulates ferroptosis in hepatic stellate cells
Zili Zhang, Mei Guo, Min Shen, et al.
Redox Biology (2020) Vol. 36, pp. 101619-101619
Open Access | Times Cited: 153
Liver fibrosis: Pathophysiology and clinical implications
Jennifer Berumen, Jacopo Baglieri, Tatiana Kisseleva, et al.
WIREs Mechanisms of Disease (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 147
Crosstalk between Oxidative Stress and Inflammatory Liver Injury in the Pathogenesis of Alcoholic Liver Disease
Yoon Mee Yang, Ye Eun Cho, Seonghwan Hwang
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 774-774
Open Access | Times Cited: 134
Alcohol-Related Liver Disease: Basic Mechanisms and Clinical Perspectives
Szu-Yi Liu, I‐Ting Tsai, Yin-Chou Hsu
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 10, pp. 5170-5170
Open Access | Times Cited: 102
Gut liver brain axis in diseases: the implications for therapeutic interventions
Mengyao Yan, Shuli Man, Benyue Sun, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 75
Toward More Accurate Nomenclature for Fatty Liver Diseases
Mohammed Eslam, Arun J. Sanyal, Jacob George
Gastroenterology (2019) Vol. 157, Iss. 3, pp. 590-593
Open Access | Times Cited: 107
Non-alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease: Two Intertwined Entities
Francisco Idalsoaga, Anand V. Kulkarni, Omar Y. Mousa, et al.
Frontiers in Medicine (2020) Vol. 7
Open Access | Times Cited: 99
Methionine metabolism in chronic liver diseases: an update on molecular mechanism and therapeutic implication
Zhanghao Li, Feixia Wang, Baoyu Liang, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 88
Green Tea and Epigallocatechin Gallate (EGCG) for the Management of Nonalcoholic Fatty Liver Diseases (NAFLD): Insights into the Role of Oxidative Stress and Antioxidant Mechanism
Guo‐Yi Tang, Yu Xu, Cheng Zhang, et al.
Antioxidants (2021) Vol. 10, Iss. 7, pp. 1076-1076
Open Access | Times Cited: 84
Gut Dysfunction and Non-alcoholic Fatty Liver Disease
Felix Grabherr, Christoph Grander, Maria Effenberger, et al.
Frontiers in Endocrinology (2019) Vol. 10
Open Access | Times Cited: 83
Antrodin A fromAntrodia camphoratamodulates the gut microbiome and liver metabolome in mice exposed to acute alcohol intake
Zhen-Wei Yi, Xiaofeng Liu, Lihong Liang, et al.
Food & Function (2021) Vol. 12, Iss. 7, pp. 2925-2937
Closed Access | Times Cited: 74
Insights into Manganese Superoxide Dismutase and Human Diseases
Mengfan Liu, Xueyang Sun, Boya Chen, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 15893-15893
Open Access | Times Cited: 64
Extra- and Intra-Cellular Mechanisms of Hepatic Stellate Cell Activation
Yufei Yan, Jiefei Zeng, Linhao Xing, et al.
Biomedicines (2021) Vol. 9, Iss. 8, pp. 1014-1014
Open Access | Times Cited: 59
Exploring the potential mechanism of Rhodomyrtus tomentosa (Ait.) Hassk fruit phenolic rich extract on ameliorating nonalcoholic fatty liver disease by integration of transcriptomics and metabolomics profiling
Ruimin Wang, Linling Yao, Xue Lin, et al.
Food Research International (2021) Vol. 151, pp. 110824-110824
Closed Access | Times Cited: 57
Harnessing reactive oxygen/nitrogen species and inflammation: Nanodrugs for liver injury
Min Liu, Qiong Huang, Yan Zhu, et al.
Materials Today Bio (2022) Vol. 13, pp. 100215-100215
Open Access | Times Cited: 55
The m6A methyltransferase Mettl3 deficiency attenuates hepatic stellate cell activation and liver fibrosis
Yanli Li, Xinmei Kang, Zhuowei Zhou, et al.
Molecular Therapy (2022) Vol. 30, Iss. 12, pp. 3714-3728
Open Access | Times Cited: 43
Canonical Wnt signaling promotes HSC glycolysis and liver fibrosis through an LDH-A/HIF-1α transcriptional complex
Feixia Wang, Li Chen, Desong Kong, et al.
Hepatology (2023) Vol. 79, Iss. 3, pp. 606-623
Open Access | Times Cited: 36
ROS/RNS as molecular signatures of chronic liver diseases
Zhaodi Che, Ziyuan Zhou, Siqi Li, et al.
Trends in Molecular Medicine (2023) Vol. 29, Iss. 11, pp. 951-967
Closed Access | Times Cited: 35
Candida albicans-specific Th17 cell-mediated response contributes to alcohol-associated liver disease
Su-Ling Zeng, Elisa Rosati, Carina Saggau, et al.
Cell Host & Microbe (2023) Vol. 31, Iss. 3, pp. 389-404.e7
Open Access | Times Cited: 33
Age‐dependent loss of hepatic SIRT1 enhances NLRP3 inflammasome signaling and impairs capacity for liver fibrosis resolution
Jennifer Adjei‐Mosi, Qing Sun, Steven Blake Smithson, et al.
Aging Cell (2023) Vol. 22, Iss. 5
Open Access | Times Cited: 25
Moderate alcohol consumption is associated with significant fibrosis progression in NAFLD
Julia Blomdahl, Patrik Nasr, Mattias Ekstedt, et al.
Hepatology Communications (2023) Vol. 7, Iss. 1, pp. e0003-e0003
Open Access | Times Cited: 24
Page 1 - Next Page

Scroll to top